Search
for

    Did you mean GT20029?
    GlossaryGT20029

    GT20029 is a gene that encodes a protein involved in hair follicle development and cycling. Its relevance to hair loss lies in its potential role in regulating hair growth and maintaining the health of hair follicles. Mutations or dysregulation of GT20029 may contribute to various forms of hair loss, making it a subject of interest in the study of alopecia and other hair disorders. Key distinguishing characteristics include its specific expression patterns in hair follicles and its involvement in signaling pathways that influence hair growth.

    Related Terms

    Learn

    5 / 801 results
    View more "gt20026" in learn →

    Research

    5 / 12 results
    View more "gt20026" in research →

    Community Join

    5 / 342 results

      community Gt20026 - the actual cure to hairloss?

      in Research/Science 3 weeks ago
      GT20026 is discussed as a potential treatment for hair loss that targets androgen receptors without affecting hormone levels, but it may not promote significant regrowth. It is expected to be available by 2028, with other treatments like Breezula and Clascoterone also mentioned.

      community GT20029: How It Works for Hair Loss - Hair Loss “Cure”

      in Research/Science  36 upvotes 1 month ago
      GT20029 is a potential treatment for androgenetic alopecia, addressing the root cause by targeting androgen receptors, unlike Minoxidil or Finasteride. It is seen as a preventative measure rather than a regrowth agent, with hopes for market release soon.

      community GT20029 Big Phase 2 Update Results!

      in Research/Science  51 upvotes 3 months ago
      GT20029 showed promising results for hair growth in a Phase II trial, with the 1.0% twice-weekly regimen being the most effective. Some users expressed skepticism and humor about the product's effects and market availability.

      community GT20029 Phase 2 results are out

      in Treatment  60 upvotes 3 months ago
      GT20029 shows promising results for hair loss treatment, with potential approval in China by 2026 or 2027, but U.S. approval may take longer. It could serve as an alternative to finasteride, with a potentially better side effect profile.
    View more "gt20026" in community →